Clinical Trial Update: A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients [NA]

View source ↗

Summary

A single-center prospective interventional trial investigating FPG500 for non-metastatic prostate cancer is registered and currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FPG500

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Prostate Cancer | NA | Status: NOT_YET_RECRUITING